People
Brian Bohnenkamp specializes in regulatory and compliance matters relating to drug, biotechnology and medical device companies. A partner in our FDA practice and a member of our Life Sciences group, Brian has extensive experience counseling manufacturers on fraud and abuse laws, industry codes of conduct, federal and state transparency laws and regulations, state and local gift bans, compliance program laws and sales representative licensing requirements, as well as government ethics restrictions.
With a master’s degree in healthcare administration, Brian provides counsel to companies on a variety of laws and regulations administered and enforced by FDA, OIG, DOJ, and CMS, as well as by state attorneys general, boards of pharmacy, departments of health, and similar administrative and enforcement authorities. He regularly assists manufacturers in designing and implementing comprehensive compliance programs, and conducts risk assessments, audits and other reviews of compliance programs and business activities/operations.
Brian is regarded as a national expert on life sciences transparency laws and regulations, including the federal Physician Payments Sunshine Act (aka Open Payments) and similar state laws. He provides counsel to the Ad Hoc Sunshine and State Law Compliance Group, a coalition of pharmaceutical, biotechnology and medical device manufacturers.
J.D., St. Louis University, magna cum laude
M.H.A., St. Louis University, highest distinction
B.A., Indiana University, highest distinction
District of Columbia
Illinois
June 8, 2022
Legal 500 United States 2022 Recognizes King & Spalding Practices and Lawyers Among the Top in the Nation
June 1, 2022
Chambers USA 2022 Recognizes 188 K&S Lawyers and 75 K&S Practice Groups as Leaders in Their Fields
June 10, 2021
Legal 500 United States 2021 Ranks King & Spalding Practices Among the Top in the Nation
November 18, 2022
DOJ increases scrutiny of arrangements with EHR vendors: what the ModMed settlement means for the life sciences industry
November 7, 2022
DOJ Increases Scrutiny of Arrangements with EHR Vendors: What the ModMed Settlement Means for the Life Sciences Industry
April 25, 2022
COVID-19 Health Care Fraud Enforcement on the Rise: What’s Ahead for the Life Sciences & Healthcare Industries
June 8, 2022
Legal 500 United States 2022 Recognizes King & Spalding Practices and Lawyers Among the Top in the Nation
June 1, 2022
Chambers USA 2022 Recognizes 188 K&S Lawyers and 75 K&S Practice Groups as Leaders in Their Fields
June 10, 2021
Legal 500 United States 2021 Ranks King & Spalding Practices Among the Top in the Nation
November 18, 2022
DOJ increases scrutiny of arrangements with EHR vendors: what the ModMed settlement means for the life sciences industry
November 7, 2022
DOJ Increases Scrutiny of Arrangements with EHR Vendors: What the ModMed Settlement Means for the Life Sciences Industry
April 25, 2022
COVID-19 Health Care Fraud Enforcement on the Rise: What’s Ahead for the Life Sciences & Healthcare Industries
June 8, 2022
Legal 500 United States 2022 Recognizes King & Spalding Practices and Lawyers Among the Top in the Nation
June 1, 2022
Chambers USA 2022 Recognizes 188 K&S Lawyers and 75 K&S Practice Groups as Leaders in Their Fields
June 10, 2021
Legal 500 United States 2021 Ranks King & Spalding Practices Among the Top in the Nation
J.D., St. Louis University, magna cum laude
M.H.A., St. Louis University, highest distinction
B.A., Indiana University, highest distinction
District of Columbia
Illinois